Fas receptor is upregulated in livers from non-heart-beating donors

European Surgical Research

Volumn 33, Issue 5-6, 2001, Pages 327-333

  Schnurr, C ^a   Glatzel, U ^b   Tolba, R ^a   Hirner, A ^a   Minor, T ^a,c  

^a UNIVERSITY OF BONN   (Germany)

^b BG Unfallklinik   (Germany)

^c UNIVERSITY HOSPITAL BONN   (Germany)

Author keywords

Apoptosis; Fas; Fas receptor; Ischemia; Non heart beating donor; Preservation; Reperfusion

Indexed keywords

ALANINE AMINOTRANSFERASE; FAS ANTIGEN; FAS RECEPTOR; GLUTAMATE DEHYDROGENASE; MESSENGER RNA; RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; BILE SECRETION; CELL DAMAGE; CONTROLLED STUDY; ENZYME RELEASE; HEART ARREST; IMMUNOHISTOCHEMISTRY; LIVER; LIVER CELL; LIVER FUNCTION; MALE; NONHUMAN; ORGAN DONOR; PRIORITY JOURNAL; RAT; RECEPTOR UPREGULATION; REPERFUSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; ANTIGENS, CD95; APOPTOSIS; HEART ARREST; LIVER; MALE; RATS; RATS, WISTAR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TISSUE AND ORGAN HARVESTING; TISSUE DONORS; UP-REGULATION;

EID: 0035699724     PISSN: 0014312X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000049726     Document Type: Article

References (38)

1. Arnold RM, Youngner SJ: Time is of the essence: The pressing need for comprehensive non-heart-beating cadaveric donation policies. Transplant Proc 1995;27:2913-2921.
2. Minor T, Saad S, Nagelschmidt M, Kotting M, Fu Z, Paul A, et al: Successful transplantation of porcine livers after warm ischemic insult in situ and cold preservation including postconditioning with gaseous oxygen. Transplantation 1998,65:1262-1264.
3. Casavilla A, Ramirez C, Shapiro R, Nghiem D, Miracle K, Fung JJ, et al: Liver and kidney transplantation from non-heart beating donors: The Pittsburgh experience. Transplant Proc 1995;27:710-712.
4. Jurado F, Bujan J, Mora NP, Jimenez M, Arahuetes R, Bellon JM: A histopathological study of anoxioresuscitated liver allografts. Histol Histopathol 1997;12:123-133.
5. Minor T, Chung CW, Yamamoto Y, Obara M, Saad S, Isselhard W: Evaluation of antioxidant treatment with superoxide dismutase in rat liver transplantation after warm ischemia. Eur Surg Res 1992;24:333-338.
6. Sumimoto K, Inagaki K, Yamada K, Kawasaki T, Dohi K: Reliable indices for the determination of viability of grafted liver immediately after orthotopic transplantation. Bile flow rate and cellular adenosine triphosphate level. Transplantation 1988;46:506-509.
7. Lemasters JJ, Ji S, Thurman RG: Centrilobular injury following hypoxia in isolated, perfused rat liver. Science 1981;213:661-663.
8. Majno G, Joris I: Apoptosis, oncosis, and necrosis. An overview of cell death. Am J Pathol 1995;146:3-15.
9. Kohli V, Selzner M, Madden JF, Bentley RC, Clavien PA: Endothelial cell and hepatocyte deaths occur by apoptosis after ischemia-reperfusion injury in the rat liver. Transplantation 1999,67:1099-1105.
10. Chien CT, Cheng CL, Lai WY, Hsu SM, Lee PH: Repetitive ischemia/reperfusion potentiates hepatocellular death by apoptosis. Transplant Proc 1999;31:2926-2927.
11. Wu G, Tomei LD, Bathurst IC, Zhang F, Hong CB, Issel CJ, et al: Antiapoptotic compound to enhance hypothermic liver preservation. Transplantation 1997;63:803-809.
12. Kohli V, Gao W, Camargo CAJ, Clavien PA: Calpain is a mediator of preservation-reperfusion injury in rat liver transplantation. Proc Natl Acad Sci USA 1997;94:9354-5359.
13. Gao W, Bentley RC, Madden JF, Clavien PA: Apoptosis of sinusoidal endothelial cells is a critical mechanism of preservation injury in rat liver transplantation. Hepatology 1998;27: 1652-1660.
14. Kohli V, Madden JF, Bentley RC, Clavien PA: Calpain mediates ischemic injury of the liver through modulation of apoptosis and necrosis. Gastroenterology 1999;116:168-178.
15. Natori S, Selzner M, Valentino KL, Fritz LC, Srinivasan A, Clavien PA, et al: Apoptosis of sinusoidal endothelial cells occurs during liver preservation injury by a caspase-dependent mechanism. Transplantation 1999;68:89-96.
16. Yadav SS, Sindram D, Perry DK, Calvien PA: Ischemic preconditioning protects the mouse liver by inhibition of apoptosis through a caspase-dependent pathway. Hepatology 1999;30: 1223-1231.
17. Nogae S, Miyazaki M, Kobayashi N, Saito T, Abe K, Saito H, et al: Induction of apoptosis in ischemia-reperfusion model of mouse kidney: Possible involvement of Fas. J Am Soc Nephrol 1998;9:620-631.
18. Galle PR, Hofmann WJ, Walczak H, Schaller H, Otto G, Stremmel W, et al: Involvement of the CD95 (APO-1/Fas) receptor and ligand in liver damage. J Exp Med 1995;182:1223-1230.
19. Galle PR: Apoptosis in liver disease. J Hepatol 1997;27:405-412.
20. Galle PR, Krammer PH: CD95-induced apoptosis in human liver disease. Semin Liver Dis 1998;18:141-151.
21. Hayashi N, Mita E: Fas system and apoptosis in viral hepatitis. J Gastroenterol Hepatol 1997;12:S223-S226.
22. Kondo T, Suda T, Fukuyama H, Adachi M, Nagata S: Essential roles of the Fas ligand in the development of hepatitis. Nat Med 1997;3: 409-413.
23. Ni R, Tomita Y, Matsuda K, Ichihara A, Ishimura K, Ogasawara J, et al: Fas-mediated apoptosis in primary cultured mouse hepatocytes. Exp Cell Res 1994;215:332-337.
24. Ogasawara J, Watanabe FR, Adachi M, Matsuzawa A, Kasugai T, Kitamura Y, et al: Lethal effect of the anti-Fas antibody in mice. Nature 1993;364:806-809.
25. Pinkoski MJ, Brunner T, Green DR, Lin T: Fas and Fas ligand in gut and liver. Am J Physiol Gastrointest Liver Physiol 2000;278:G354-G366.
26. Singh AK, Mani H, Seth P, Gaddipati JP, Kumari R, Banuadha KK, et al: Picroliv preconditioning protects the rat liver against ischemia-reperfusion injury. Eur J Pharmacol 2000;395:229-239.
27. Minor T, Akbar S: Enhancement of endogenous cyclic AMP signal: A new approach to allow for cold preservation of rat livers from non-heart-beating donors? Transplantation 1998;66:990-994.
28. Minor T, Yamaguchi T, Isselhard W: TI - Effects of taurine on liver preservation in UW solution with consecutive ischemic rewarming in the isolated perfused rat liver. Transpl Int 1995;8:174-179.
29. Minor T, Akbar S, Tolba R, Dombrowski F: Cold preservation of fatty liver grafts: Prevention of functional and ultrastructural impairments by venous oxygen persufflation. J Hepatol 2000;32:105-111.
30. Sgonc R, Boeck G, Dietrich H, Gruber J, Recheis H, Wick G: Simultaneous determination of cell surface antigens and apoptosis. Trends Genet 1994;10:41-42.
31. Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162:156-159.
32. Wyllie AH: glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature 1980;284:555-556.
33. Cardier JE, Schulte T, Kammer H, Kwak J, Cardier M: Fas (CD95, APO-1) antigen expression and function in murine liver endothelial cells: Implications for the regulation of apoptosis in liver endothelial cells. FASEB J 1999;13: 1950-1960.
34. Richardson BC, Lalwani ND, Johnson KJ, Marks RM: Fas ligation triggers apoptosis in macrophages but not endothelial cells. Eur J Immunol 1994;24:2640-2645.
35. Sasaki H, Matsuno T, Nakagawa K, Tanaka N: Induction of apoptosis during the early phase of reperfusion after rat liver ischemia. Acta Med Okayama 1997;51:305-312.
36. Sasaki H, Matsuno T, Nakagawa K, Matsuoka J, Tanaka N: Superoxide induces hepatocyte apoptosis during the early phase of reperfusion after murine liver ischemia. Transplant Proc 1998;30:2958-2959.
37. Faubion WA, Guicciardi ME, Miyoshi H, Bronk SF, Roberts PJ, Svingen PA, et al: Toxic bile salts induce rodent hepatocyte apoptosis via direct activation of Fas. J Clin Invest 1999; 103:137-145.
38. Stassi G, Di Felice V, Todaro M, Cappello F, Zummo G, Farina F, et al: Involvement of Fas/ FasL system in the pathogenesis of autoimmune diseases and Wilson's disease. Arch Immunol Ther Exp (Warsz) 1999;47:129-133.